Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,444
  • Shares Outstanding, K 52,403
  • Annual Sales, $ 31,910 K
  • Annual Income, $ -26,080 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.19
  • Price/Sales 0.63
  • Price/Cash Flow N/A
  • Price/Book 0.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.02 on 03/17/25
  • Next Earnings Date 06/12/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.100 on 11/15/24
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2520 +24.52%
on 04/04/25
0.5344 -41.28%
on 03/19/25
-0.1563 (-33.25%)
since 03/17/25
3-Month
0.2520 +24.52%
on 04/04/25
0.6868 -54.31%
on 01/22/25
-0.3412 (-52.09%)
since 01/17/25
52-Week
0.2520 +24.52%
on 04/04/25
1.2750 -75.39%
on 05/29/24
-0.8362 (-72.71%)
since 04/17/24

Most Recent Stories

More News
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y

Shares of Enzo Biochem, Inc. ENZ have lost 0.7% since the company reported its earnings for the quarter ended Jan. 31, 2025. This compares to the S&P 500 Index’s 0.6% gain over the same time frame. Over...

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges

Shares of Enzo Biochem, Inc. ENZ have tumbled 30.9% since the release of its earnings report for the quarter ended Oct. 31, 2024. This compares unfavorably with the S&P 500 Index's 2.9% decline over the...

ENZ : 0.3138 (-17.77%)
Enzo Biochem, Inc. Reports Fiscal Q1 2024 Financial Results and Declares Special Cash Dividend

Enzo Biochem reported a revenue decline of 20% in Q1 2024, alongside strategic leadership changes and a special cash dividend.Quiver AI SummaryEnzo Biochem, Inc. announced its financial results for the...

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.3138 (-17.77%)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.3138 (-17.77%)

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

3rd Resistance Point 0.4575
2nd Resistance Point 0.4287
1st Resistance Point 0.3713
Last Price 0.3138
1st Support Level 0.2851
2nd Support Level 0.2563
3rd Support Level 0.1989

See More

52-Week High 1.2750
Fibonacci 61.8% 0.8842
Fibonacci 50% 0.7635
Fibonacci 38.2% 0.6428
Last Price 0.3138
52-Week Low 0.2520

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar